179 related articles for article (PubMed ID: 8735139)
1. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in patients with lupus anticoagulant and implications for thrombosis.
Sailer T; Vormittag R; Pabinger I; Vukovich T; Lehr S; Quehenberger P; Panzer S; Lechner K; Zoghlami-Rintelen C
J Rheumatol; 2005 Mar; 32(3):462-8. PubMed ID: 15742437
[TBL] [Abstract][Full Text] [Related]
5. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
7. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
9. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
11. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F; Samama M
Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
[TBL] [Abstract][Full Text] [Related]
12. [Clinical diagnosis of thrombosis and blood coagulation tests].
Watanabe K
Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
[TBL] [Abstract][Full Text] [Related]
13. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
Gargiulo P; Schiaffini R; Bosco D; Ciampalini P; Pantaleo A; Romani B; Arcieri P; Andreani D
Diabet Med; 1997 Feb; 14(2):132-7. PubMed ID: 9047090
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM
Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323
[TBL] [Abstract][Full Text] [Related]
15. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
16. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
17. High incidence of thrombophilia detected in Chinese patients with venous thrombosis.
Liu HW; Kwong YL; Bourke C; Lam CK; Lie AK; Wei D; Chan LC
Thromb Haemost; 1994 Apr; 71(4):416-9. PubMed ID: 8052955
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
19. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
20. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]